IP Library Granted Patent US 7,691,429
Granted Patent B2
US 7,691,429 · App. 11/232,781 · Granted Apr 6, 2010

Nutritional supplements containing methylselenocysteine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,429
App. No.
11/232,781
Granted
Apr 6, 2010
Kind
B2
Abstract

A method of producing metal-rich plants for the production of nutritional supplements. Edible plants are placed in a growth environment containing metal, and are cultivated in a fashion which enhances the uptake of metal into edible portions of the plants. The plants are then harvested, and may be eaten directly or processed into capsule or tablet form, in order to obtain the metallic nutrients so incorporated.

Claims (6)

1. A nutritional supplement comprising the edible portions of a plant which has been induced to hyperaccumulate selenium in its edible portions, and which has been incorporated into one or more of processed food, a capsule, a tablet, a powder, a gel, and a liquid, wherein the plant is a member of the family Brassicaceae, and wherein the plant hyperaccumulates at least 400 parts per million dry weight of nutritionally valuable selenium in at least some of its edible portions.

2. The nutritional supplement of claim 1 , wherein the inducing agent is an organic acid.

3. The nutritional supplement of claim 2 , wherein the inducing agent is selected from a group consisting of citric acid, acetic acid, malic acid, salicylic acid and succinic acid.

4. A nutritional supplement according to claim 1 , wherein the accumulated selenium is in the form of Se-methylselenocysteine.

5. The nutritional supplement of claim 4 , wherein the inducing agent is an organic acid.

6. The nutritional supplement of claim 4 , wherein the inducing agent is selected from a group consisting of citric acid, acetic acid, malic acid, salicylic acid and succinic acid.

Assignments (4)
CHANGE OF NAME Recorded Jan 13, 2010
From: IBIOPHARMA, INC.
To: IBIO, INC.
Reel/Frame 023774/0912 →
MERGER Recorded Jun 11, 2009
From: INB:BIOTECHNOLOGIES, INC.
To: IBIOPHARMA, INC.
Reel/Frame 022814/0885 →
CHANGE OF NAME Recorded Jun 11, 2009
From: NUCYCLE THERAPY, INC.
To: INB:BIOTECHNOLOGIES, INC.
Reel/Frame 022815/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2009
From: SALT, DAVID; ENSLEY, BURT D.; ORSER, CYNTHIA
To: NUCYCLE THERAPY, INC.
Reel/Frame 022741/0074 →